Transcriptional control of genes for soluble complement cascade regulatory proteins

Molecular Immunology

Volumn 48, Issue 1-3, 2010, Pages 9-13

  Fraczek, Laura A ^a,b   Martin, Brian K ^a,c  

^a Iowa Cancer Research Foundation   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c New Link Genetics Corporation   (United States)

Author keywords

C1 inhibitor; C4 binding protein; Complement; Complement factor H; Complement factor I; Transcription

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; REGULATOR PROTEIN;

COMPLEMENT FACTOR; COMPLEMENT SYSTEM; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS;

EID: 78649513066     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.08.016     Document Type: Review

References (70)

1. Abrera-Abeleda M.A., Nishimura C., Smith J.L., Sethi S., McRae J.L., Murphy B.F., Silvestri G., Skerka C., Jozsi M., Zipfel P.F., Hageman G.S., Smith R.J. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J. Med. Genet. 2006, 43:582-589.
2. Arenzana N., Rodriguez de Cordoba S. Promoter region of the human gene coding for beta-chain of C4b binding protein. Hepatocyte nuclear factor-3 and nuclear factor-I/CTF transcription factors are required for efficient expression of C4BPB in HepG2 cells. J. Immunol. 1996, 156:168-175.
3. Arenzana N., Rodriguez de Cordoba S., Rey-Campos J. Expression of the human gene coding for the alpha-chain of C4b-binding protein, C4BPA, is controlled by an HNF1-dependent hepatic-specific promoter. Biochem. J. 1995, 308(Pt 2):613-621.
4. Avery V.M., Gordon D.L. Characterization of factor H binding to human polymorphonuclear leukocytes. J. Immunol. 1993, 151:5545-5553.
5. Barnum S.R., Kristensen T., Chaplin D.D., Seldin M.F., Tack B.F. Molecular analysis of the murine C4b-binding protein gene. Chromosome assignment and partial gene organization. Biochemistry 1989, 28:8312-8317.
6. Caprioli J., Bettinaglio P., Zipfel P.F., Amadei B., Daina E., Gamba S., Skerka C., Marziliano N., Remuzzi G., Noris M. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J. Am. Soc. Nephrol. 2001, 12:297-307.
7. Carroll M.C., Alicot E.M., Katzman P.J., Klickstein L.B., Smith J.A., Fearon D.T. Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1. J. Exp. Med. 1988, 167:1271-1280.
8. Cheng Z.Z., Hellwage J., Seeberger H., Zipfel P.F., Meri S., Jokiranta T.S. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol. Immunol. 2006, 43:972-979.
9. Criado Garcia O., Sanchez-Corral P., Rodriguez de Cordoba S. Isoforms of human C4b-binding protein. II. Differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. J. Immunol. 1995, 155:4037-4043.
10. D'Eustachio P., Kristensen T., Wetsel R.A., Riblet R., Taylor B.A., Tack B.F. Chromosomal location of the genes encoding complement components C5 and factor H in the mouse. J. Immunol. 1986, 137:3990-3995.
11. de Cordoba S.R., Ferreira A., Nussenzweig V., Rubinstein P. Genetic polymorphism of human C4-binding protein. J. Immunol. 1983, 131:1565-1569.
12. Dierich M.P., Erdei A., Gergely J., Myones B.L., Schulz T.F. Complement-dependent triggering of B-cells, T-cells and macrophages. Behring Inst. Mitt. 1987, 128-132.
13. DiScipio R.G., Daffern P.J., Schraufstatter I.U., Sriramarao P. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18). J. Immunol. 1998, 160:4057-4066.
14. Esparza-Gordillo J., Goicoechea de Jorge E., Buil A., Carreras Berges L., Lopez-Trascasa M., Sanchez-Corral P., Rodriguez de Cordoba S. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum. Mol. Genet. 2005, 14:703-712.
15. Farries T.C., Seya T., Harrison R.A., Atkinson J.P. Competition for binding sites on C3b by CR1, CR2, MCP, factor B and Factor H. Complement Inflamm. 1990, 7:30-41.
16. Fremeaux-Bacchi V., Kemp E.J., Goodship J.A., Dragon-Durey M.A., Strain L., Loirat C., Deng H.W., Goodship T.H. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J. Med. Genet. 2005, 42:852-856.
17. Friese M.A., Hellwage J., Jokiranta T.S., Meri S., Peter H.H., Eibel H., Zipfel P.F. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol. 1999, 36:809-818.
18. Fujita T., Kamato T., Tamura N. Characterization of functional properties of C4-binding protein by monoclonal antibodies. J. Immunol. 1985, 134:3320-3324.
19. Gompels M.M., Lock R.J., Abinun M., Bethune C.A., Davies G., Grattan C., Fay A.C., Longhurst H.J., Morrison L., Price A., Price M., Watters D. C1 inhibitor deficiency: consensus document. Clin. Exp. Immunol. 2005, 139:379-394.
20. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7227-7232.
21. Hellwage J., Eberle F., Babuke T., Seeberger H., Richter H., Kunert A., Hartl A., Zipfel P.F., Jokiranta T.S., Jozsi M. Two factor H-related proteins from the mouse: expression analysis and functional characterization. Immunogenetics 2006, 58:883-893.
22. Hellwage J., Jokiranta T.S., Koistinen V., Vaarala O., Meri S., Zipfel P.F. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett. 1999, 462:345-352.
23. Hing S., Day A.J., Linton S.J., Ripoche J., Sim R.B., Reid K.B., Solomon E. Assignment of complement components C4 binding protein (C4BP) and factor H (FH) to human chromosome 1q, using cDNA probes. Ann. Hum. Genet. 1988, 52:117-122.
24. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177.
25. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 2000, 275:27657-27662.
26. Jozsi M., Licht C., Strobel S., Zipfel S.L., Richter H., Heinen S., Zipfel P.F., Skerka C. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 2008, 111:1512-1514.
27. Kain S.J., Maldonado M.J., Vik D.P. Analysis of the promoter region of the murine complement factor H gene. Biochim. Biophys. Acta 1998, 1397:241-246.
28. Kim Y.H., He S., Kase S., Kitamura M., Ryan S.J., Hinton D.R. Regulated secretion of complement factor H by RPE and its role in RPE migration. Graefes. Arch. Clin. Exp. Ophthalmol. 2009.
29. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
30. Lappin D., Whaley K. Regulation of C1-inhibitor synthesis by interferons and other agents. Behring Inst. Mitt. 1989, 180-192.
31. Lappin D.F., Birnie G.D., Whaley K. Interferon-mediated transcriptional and post-transcriptional modulation of complement gene expression in human monocytes. Eur. J. Biochem. 1990, 194:177-184.
32. Lappin D.F., Guc D., Hill A., McShane T., Whaley K. Effect of interferon-gamma on complement gene expression in different cell types. Biochem. J. 1992, 281(Pt 2):437-442.
33. Lappin D.F., Whaley K. Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem. J. 1990, 271:767-772.
34. Legoedec J., Gasque P., Jeanne J.F., Fontaine M. Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur. J. Immunol. 1995, 25:3460-3466.
35. Lener M., Vinci G., Duponchel C., Meo T., Tosi M. Molecular cloning, gene structure and expression profile of mouse C1 inhibitor. Eur. J. Biochem. 1998, 254:117-122.
36. McRae J.L., Duthy T.G., Griggs K.M., Ormsby R.J., Cowan P.J., Cromer B.A., McKinstry W.J., Parker M.W., Murphy B.F., Gordon D.L. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 2005, 174:6250-6256.
37. Minta J., Fung M. Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation. Mol. Cell. Biochem. 1999, 201:111-123.
38. Minta J.O., Fung M., Paramaswara B. Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6. Biochim. Biophys. Acta 1998, 1442:286-295.
39. Minta J.O., Fung M., Turner S., Eren R., Zemach L., Rits M., Goldberger G Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene. Gene 1998, 208:17-24.
40. Minta J.O., Wong M.J., Kozak C.A., Kunnath-Muglia L.M., Goldberger G. cDNA cloning, sequencing and chromosomal assignment of the gene for mouse complement factor I (C3b/C4b inactivator): identification of a species specific divergent segment in factor I. Mol. Immunol. 1996, 33:101-112.
41. Moore I., Strain L., Pappworth I., Kavanagh D., Barlow P.N., Herbert A.P., Schmidt C.Q., Staniforth S.J., Holmes L.V., Ward R., Morgan L., Goodship T.H., Marchbank K.J. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical haemolytic uraemic syndrome. Blood 2009.
42. Munoz-Canoves P., Tack B.F., Vik D.P. Analysis of complement factor H mRNA expression: dexamethasone and IFN-gamma increase the level of H in L cells. Biochemistry 1989, 28:9891-9897.
43. Nabil K., Rihn B., Jaurand M.C., Vignaud J.M., Ripoche J., Martinet Y., Martinet N. Identification of human complement factor H as a chemotactic protein for monocytes. Biochem. J. 1997, 326(Pt 2):377-383.
44. Nakamura S., Abe K. Genetic polymorphism of human factor I (C3b inactivator). Hum. Genet. 1985, 71:45-48.
45. Ohtsuka H., Imamura T., Matsushita M., Tanase S., Okada H., Ogawa M., Kambara T. Thrombin generates monocyte chemotactic activity from complement factor H. Immunology 1993, 80:140-145.
46. Ormsby R.J., Jokiranta T.S., Duthy T.G., Griggs K.M., Sadlon T.A., Giannakis E., Gordon D.L. Localization of the third heparin-binding site in the human complement regulator factor H1. Mol. Immunol. 2006, 43:1624-1632.
47. Pangburn M.K. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 2000, 49:149-157.
48. Pickering M.C., Cook H.T. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin. Exp. Immunol. 2008, 151:210-230.
49. Pickering M.C., Cook H.T., Warren J., Bygrave A.E., Moss J., Walport M.J., Botto M. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 2002, 31:424-428.
50. Prada A.E., Zahedi K., Davis A.E. Regulation of C1 inhibitor synthesis. Immunobiology 1998, 199:377-388.
51. Prosser B.E., Johnson S., Roversi P., Herbert A.P., Blaum B.S., Tyrrell J., Jowitt T.A., Clark S.J., Tarelli E., Uhrin D., Barlow P.N., Sim R.B., Day A.J., Lea S.M. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 2007, 204:2277-2283.
52. Rasmussen J.M. Inherited deficiencies of complement proteins with special reference to congenital deficiency of the regulatory protein factor I. APMIS Suppl. 1991, 22:1-48.
53. Rougier N., Kazatchkine M.D., Rougier J.P., Fremeaux-Bacchi V., Blouin J., Deschenes G., Soto B., Baudouin V., Pautard B., Proesmans W., Weiss E., Weiss L. Human complement factor H deficiency associated with hemolytic uremic syndrome. J. Am. Soc. Nephrol. 1998, 9:2318-2326.
54. Sanchez-Corral P., Criado Garcia O., Rodriguez de Cordoba S. Isoforms of human C4b-binding protein. I. Molecular basis for the C4BP isoform pattern and its variations in human plasma. J. Immunol. 1995, 155:4030-4036.
55. Schlaf G., Rothermel E., Oppermann M., Schieferdecker H.L., Jungermann K., Gotze O. Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells. Immunology 1999, 98:464-474.
56. Schmidt C.Q., Herbert A.P., Kavanagh D., Gandy C., Fenton C.J., Blaum B.S., Lyon M., Uhrin D., Barlow P.N. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 2008, 181:2610-2619.
57. Sim R.B., Malhotra V., Ripoche J., Day A.J., Micklem K.J., Sim E. Complement receptors and related complement control proteins. Biochem. Soc. Symp. 1986, 51:83-96.
58. Strohmeyer R., Ramirez M., Cole G.J., Mueller K., Rogers J. Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. J. Neuroimmunol. 2002, 131:135-146.
59. Turnberg D., Botto M. The regulation of the complement system: insights from genetically-engineered mice. Mol. Immunol. 2003, 40:145-153.
60. Vastag M., Skopal J., Kramer J., Kolev K., Voko Z., Csonka E., Machovich R., Nagy Z. Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4. Immunobiology 1998, 199:5-13.
61. Vik D.P. Regulation of expression of the complement factor H gene in a murine liver cell line by interferon-gamma. Scand. J. Immunol. 1996, 44:215-222.
62. Vinci G., Lynch N.J., Duponchel C., Lebastard T.M., Milon G., Stover C., Schwaeble W., Tosi M. In vivo biosynthesis of endogenous and of human C1 inhibitor in transgenic mice: tissue distribution and colocalization of their expression. J. Immunol. 2002, 169:5948-5954.
63. Warwicker P., Goodship T.H., Goodship J.A. Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics 1997, 46:437-438.
64. Wenderfer S.E., Soimo K., Wetsel R.A., Braun M.C. Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. Arthritis Res. Ther. 2007, 9:R114.
65. Williams S.A., Vik D.P. Characterization of the 5' flanking region of the human complement factor H gene. Scand. J. Immunol. 1997, 45:7-15.
66. Zahedi K., Bissler J.J., Prada A.E., Prada J.A., Davis A.E. The promoter of the C1 inhibitor gene contains a polypurine-polypyrimidine segment that enhances transcriptional activity. J. Immunol. 1999, 162:7249-7255.
67. Zahedi K., Prada A.E., Davis A.E. Structure and regulation of the C1 inhibitor gene. Behring Inst. Mitt. 1993, 115-119.
68. Zahedi K., Prada A.E., Mulligan A., Prada J.A., Davis A.E. Normal transcription of the C1 inhibitor gene is dependent upon a polypurine-polypyrimidine region within the promoter. Inflammation 2002, 26:183-191.
69. Zahedi K., Prada A.E., Prada J.A., Davis A.E. Characterization of the IFN-gamma-responsive element in the 5' flanking region of the C1 inhibitor gene. J. Immunol. 1997, 159:6091-6096.
70. Zipfel P.F., Jokiranta T.S., Hellwage J., Koistinen V., Meri S. The factor H protein family. Immunopharmacology 1999, 42:53-60.